PEAK6’s Bio-Techne TECH Stock Holding History

PEAK6’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.8M	Buy	+67,942	New	+$3.67M	0.01%	870

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

PEAK6's TECH Position: Q2 2026 in Review

PEAK6 opened a new position in Bio-Techne (TECH) in Q2 2026: 67,942 shares worth $4.8M. The stake represents 0.01% of the portfolio and ranks #870 among its holdings.

597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

PEAK6 held 67,942 shares of Bio-Techne worth $4.8M as of Q2 2026.
Bio-Techne was a new PEAK6 position in Q2 2026.
Bio-Techne made up 0.01% of PEAK6's portfolio in Q2 2026, its #870 holding.
597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.